Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment

Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment

In order to meet the challenges in data evaluation and comparability between studies in multiple myeloma (MM) minimal residual disease (MRD) assessment, the goal of the current study was to provide a step-by-step evaluation of next-generation sequencing (NGS) and multicolor flow cytometry (MFC) data...

Full description

Bibliographic Details
Main Authors: Katharina Kriegsmann, Michael Hundemer, Nicole Hofmeister-Mielke, Philipp Reichert, Calin-Petru Manta, Mohamed H.S. Awwad, Sandra Sauer, Uta Bertsch, Britta Besemer, Roland Fenk, Mathias Hänel, Markus Munder, Katja C. Weisel, Igor W. Blau, Andreas Neubauer, Carsten Müller-Tidow, Marc S. Raab, Hartmut Goldschmidt, Stefanie Huhn, for the German-speaking Myeloma Multicenter Group (GMMG)
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
multiple myeloma (MM)
minimal residual disease (MRD)
next-generation sequencing (NGS)
multicolor flow cytometry (MFC)
EuroFlow
Online Access:https://www.mdpi.com/2072-6694/12/8/2322

Internet

https://www.mdpi.com/2072-6694/12/8/2322

Similar Items